Discovering a potential explanation for treatment resistance in skin cancer
Take-home antibiotic therapies may improve health outcomes for patients with drug use-associated infective endocarditis
28 February 2022Adaptive platform trial hopes to bring new treatments to patients faster
28 February 2022Discovering a potential explanation for treatment resistance in skin cancer
Many melanoma patients are treated with drugs called BRAF or MEK inhibitors that specifically target the mutant proteins created in cancerous tumors. These inhibitors can block the tumors’ ability to grow and spread.
